07/17/2026
The U.S. Food and Drug Administration (FDA) has cleared a groundbreaking technology called histotripsy, which uses precisely focused ultrasound waves to destroy targeted tissue without making surgical incisions. Instead of cutting into the body, the technique delivers controlled sound energy that mechanically breaks tumor tissue into tiny fragments. 🔊🩺
The FDA’s initial clearance covers the destruction of targeted liver tumors. Histotripsy works by creating microscopic bubbles within the tissue that rapidly expand and collapse, disrupting tumor cells while aiming to spare surrounding healthy structures.
Because the procedure is non-invasive, it could offer benefits such as shorter recovery times and fewer procedure-related complications for some patients, including those who may not be ideal candidates for traditional surgery. Researchers are now studying whether the technology could also be useful against tumors in other parts of the body. 🔬
Histotripsy won’t replace every form of cancer treatment, but it marks an exciting step forward in image-guided, non-invasive tumor care. 🎯✨
